+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Celgene Corporation - logo

Celgene is a global biopharmaceuticals company with a focus on target identification and drug discovery for cancer as well as treatments for other serious immune disorders. Alongside their research in drug discovery, Celgene maintains a strong focus on patient support through their team of Celgene Patient Support Specialists. Celgene’s portfolio includes therapies such as Abraxane, Istodax, Otezla, Pomalyst and Vidaza.

Bile Duct Cancer Drug Market by Type, Gemcitabine, Cisplatin, Capecitabine, Oxaliplatin, and Others and by Application: Global Industry Perspective, Comprehensive Analysis, and Forecast, 2017-2024 - Product Thumbnail Image

Bile Duct Cancer Drug Market by Type, Gemcitabine, Cisplatin, Capecitabine, Oxaliplatin, and Others and by Application: Global Industry Perspective, Comprehensive Analysis, and Forecast, 2017-2024

  • Report
  • January 2019
  • 110 Pages
From
Cancer Immunotherapy Market By Type (Monoclonal Antibodies, Checkpoint Inhibitors, Immunomodulators, Vaccines, Cell Therapy), Application (Lung, Breast, Multiple Myeloma, Colorectal, Melanoma, Prostate), And End User– Global Forecast To 2024 - Product Thumbnail Image

Cancer Immunotherapy Market By Type (Monoclonal Antibodies, Checkpoint Inhibitors, Immunomodulators, Vaccines, Cell Therapy), Application (Lung, Breast, Multiple Myeloma, Colorectal, Melanoma, Prostate), And End User– Global Forecast To 2024

  • Report
  • November 2018
  • 173 Pages
From
Global Drug Adherence Market: Focus on Smart Delivery Devices (Smart Inhalers, Injectors, Wearable Injectors, Pills) and Smart Accessories (Medication Dispensers, Pill Bottles / Boxes, Blister Packs) - Product Thumbnail Image

Global Drug Adherence Market: Focus on Smart Delivery Devices (Smart Inhalers, Injectors, Wearable Injectors, Pills) and Smart Accessories (Medication Dispensers, Pill Bottles / Boxes, Blister Packs)

  • Report
  • October 2018
  • 450 Pages
From
Abraxane - Product Thumbnail Image

Abraxane

  • Report
  • August 2018
  • 48 Pages
From
World Paclitaxel Injection Market - Opportunities and Forecasts, 2017 - 2023 - Product Thumbnail Image

World Paclitaxel Injection Market - Opportunities and Forecasts, 2017 - 2023

  • Report
  • September 2019
From
Global Regenerative Medicine Market Analysis & Forecast to 2023; Stem Cells, Tissue Engineering, BioBanking & CAR-T Industries - Product Thumbnail Image

Global Regenerative Medicine Market Analysis & Forecast to 2023; Stem Cells, Tissue Engineering, BioBanking & CAR-T Industries

  • Report
  • January 2019
  • 700 Pages
From
Abraxane 2019 U.S. Promotional Audit Report - Product Thumbnail Image

Abraxane 2019 U.S. Promotional Audit Report

  • Report
  • July 2020
  • 27 Pages
From
Global Regenerative Medicine Market Analysis & Forecast to 2021 - Stem Cells, Tissue Engineering, BioBanking & CAR-T Industries - Product Thumbnail Image

Global Regenerative Medicine Market Analysis & Forecast to 2021 - Stem Cells, Tissue Engineering, BioBanking & CAR-T Industries

  • Drug Pipelines
  • May 2017
  • 682 Pages
From
Psoriasis Therapeutics in Asia-Pacific Markets to 2024 - Increasing Prevalence, Advent of Novel Biologics and Pipeline Drugs to Drive the Market - Product Thumbnail Image

Psoriasis Therapeutics in Asia-Pacific Markets to 2024 - Increasing Prevalence, Advent of Novel Biologics and Pipeline Drugs to Drive the Market

  • Report
  • June 2018
  • 125 Pages
From
T-Cell & NK-Cell Engaging Bispecific Antibodies 2019: A Business, Stakeholder, Technology and Pipeline Analysis - Product Thumbnail Image

T-Cell & NK-Cell Engaging Bispecific Antibodies 2019: A Business, Stakeholder, Technology and Pipeline Analysis

  • Report
  • June 2019
  • 463 Pages
From
Global Licensing Partnering Terms & Agreements in Pharma, Biotech & Diagnostics 2014-2020 - Product Thumbnail Image

Global Licensing Partnering Terms & Agreements in Pharma, Biotech & Diagnostics 2014-2020

  • Report
  • April 2020
  • 2000 Pages
From
Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014 to 2020 - Product Thumbnail Image

Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014 to 2020

  • Report
  • April 2020
  • 400 Pages
From
Report package: T-Cell Immunotherapy by Bispecific Antibodies and CAR & TCR Engineered T-cells - Product Thumbnail Image

Report package: T-Cell Immunotherapy by Bispecific Antibodies and CAR & TCR Engineered T-cells

  • Report
  • September 2016
  • 618 Pages
From
Global Monoclonal Antibody Partnering Terms and Agreements 2014 to 2020 - Product Thumbnail Image

Global Monoclonal Antibody Partnering Terms and Agreements 2014 to 2020

  • Report
  • June 2020
  • 500 Pages
From
Psoriasis Drugs Market Analysis Report by Therapeutic Class (Interleukin-inhibitors, Tumor Necrosis Factor-inhibitors), by Treatment (Topicals, Systemic, Biologics), and Segment Forecasts, 2016 - 2022 - Product Thumbnail Image

Psoriasis Drugs Market Analysis Report by Therapeutic Class (Interleukin-inhibitors, Tumor Necrosis Factor-inhibitors), by Treatment (Topicals, Systemic, Biologics), and Segment Forecasts, 2016 - 2022

  • Report
  • September 2018
  • 115 Pages
From
Global Discovery Stage Partnering Terms and Agreements in Pharma and Biotech 2014- 2020 - Product Thumbnail Image

Global Discovery Stage Partnering Terms and Agreements in Pharma and Biotech 2014- 2020

  • Report
  • March 2020
  • 1500 Pages
From
Global Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech & Diagnostics 2014-2020 - Product Thumbnail Image

Global Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech & Diagnostics 2014-2020

  • Report
  • April 2020
  • 250 Pages
From
2019 AIDS Related Cancer Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025 - Product Thumbnail Image

2019 AIDS Related Cancer Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • Report
  • April 2019
  • 54 Pages
From
The Future of the U.S. Biologics and Biosimilars Treatment Market for Psoriasis - Product Thumbnail Image

The Future of the U.S. Biologics and Biosimilars Treatment Market for Psoriasis

  • Report
  • October 2017
  • 104 Pages
From
2019 Systemic Sclerosis (Scleroderma) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025 - Product Thumbnail Image

2019 Systemic Sclerosis (Scleroderma) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • Report
  • April 2019
  • 194 Pages
From
Loading Indicator
adroll